Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Food Allergy Sufferers Unite: Solutions Loom – and Profits, Too

We've been promising you another "peanut allergy" stock.

Today we're keeping that promise.

And the timing couldn't be better.

Shares of Neogen Corp. (Nasdaq: NEOG) - a maker of allergen-detector kits - have soared nearly 40% since Radical Technology Profits Editor Michael Robinson told us about the company back in April 2014.

And Aimmune Therapeutics Inc. (Nasdaq: AIMT) - a Brisbane, Calif.-based biotech that's developed one of the first true treatments for food-allergy sufferers - last week proved itself to be every bit the hot initial public offering (IPO) that we've been expecting. In a rare move for us, we recommended the IPO and then watched as the company's shares rocketed 50% on their first day of trading.

We'd promised to circle back with one more recommendation.

And here it is...

Full Story

Leave a Reply

Your email address will not be published. Required fields are marked *

Some HTML is OK